- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Buy the Dip
Global Pharmaceuticals & Biotech Buy the Dip
Results
30
22 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
30 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
6446 New | NT$640.00 | -16.6% | 97.5% | NT$213.0b | NT$844.80 | PE115.4x | E71.8% | n/a | ||
4587 New | JP¥2,116.00 | -9.1% | 38.4% | JP¥274.3b | JP¥3,457.14 | PE18.3x | E7.9% | n/a | ||
PRAX New | US$74.49 | -17.9% | 78.9% | US$1.4b | US$160.45 | PS893.4x | E29.7% | n/a | ||
CDNA New | US$22.29 | -9.0% | 169.5% | US$1.2b | US$32.86 | PS3.8x | E94.3% | n/a | ||
PAHC New | US$22.50 | -12.7% | 74.7% | US$911.3m | US$21.00 | PE47.2x | E66.1% | 2.1% | ||
QURE New | US$12.84 | -9.4% | 103.2% | US$686.1m | US$35.49 | PS24x | E50.5% | n/a | ||
MNMD New | US$7.63 | -22.9% | 55.4% | US$559.5m | US$25.60 | PB2.1x | E42.8% | n/a | ||
OXB New | UK£3.45 | -11.5% | 103.7% | UK£365.6m | UK£5.30 | PS3.8x | E96.4% | n/a | ||
STOK New | US$8.33 | -22.0% | 40.2% | US$441.2m | US$23.88 | PS26.4x | E1.5% | n/a | ||
EBS New | US$7.71 | -20.7% | 181.4% | US$417.8m | US$13.50 | PS0.4x | E117.1% | n/a | ||
A053030 | ₩18,100.00 | -8.4% | 59.3% | ₩576.4b | ₩30,700.00 | PS4.4x | S31.2% | n/a | ||
CMPX | US$2.92 | -13.6% | 63.1% | US$401.8m | US$11.22 | PS472.7x | E54.3% | n/a | ||
TKNO | US$7.45 | -10.0% | 115.9% | US$397.1m | US$10.67 | PS10.9x | E22.8% | n/a | ||
AKBA New | US$1.80 | -15.5% | 33.3% | US$392.7m | US$7.17 | PS2.3x | E56.3% | n/a | ||
ETON New | US$14.51 | -11.6% | 224.6% | US$374.9m | US$25.67 | PS10.8x | E46.8% | n/a | ||
ABOT New | PK₨1,040.75 | -15.4% | 117.5% | PK₨101.9b | n/a | PE20.4x | n/a | 0% | ||
CDTX New | US$21.54 | -10.0% | 53.9% | US$235.6m | US$31.50 | PS5.3x | E4.4% | n/a | ||
BSEM | US$13.80 | -10.5% | 59.5% | US$229.8m | US$32.50 | PE14.5x | E33.8% | n/a | ||
PLX New | US$2.39 | -11.2% | 64.8% | US$176.0m | US$14.50 | PS3.9x | E123.8% | n/a | ||
506414 New | ₹268.50 | -10.2% | 36.9% | ₹7.9b | n/a | PE22.2x | n/a | 0.5% | ||
SANION | SEK 7.12 | -11.4% | 260.0% | SEK 801.2m | SEK 11.00 | PS30.1x | S38.0% | n/a | ||
XGN | US$3.58 | -15.4% | 74.6% | US$63.1m | US$7.00 | PS1.1x | E37.4% | n/a | ||
ETST New | US$0.17 | -19.0% | 118.4% | US$50.2m | n/a | PE21.7x | n/a | n/a | ||
XLO New | US$0.93 | -18.4% | 59.8% | US$42.5m | US$4.50 | PS9.2x | E-22.4% | n/a |